Spirits Cap Corp.
SSCC News Today: Stay Updated with the Latest Spirits Cap Corp. News in Real Time
Find SSCC news now at Meyka AI. Stay informed with the latest Spirits Cap Corp. stocks updates, including price news, market analysis, and expert insights.
AEC1.DE American Express Earnings Preview April 23
American Express earnings preview for April 23, 2026. Analysts expect $3.47 EPS and $16.11B revenue. Key metrics and what to watch.
AEC1.DE American Express Earnings Preview April 23
American Express earnings preview: $3.47 EPS and $16.11B revenue expected April 23. Key metrics and analyst expectations.
Nestle India Stock Jumps 3% After Strong Q4 Beat; Brokerages Split on Valuation
On April 21, 2026, Nestle India surprised the market with a strong Q4 FY26 earnings beat. The company reported a sharp rise in both profit and revenue, driven by steady demand across its core FMCG products. Net profit jumped around 26-27% year-on-year, while revenue grew more than 22%, showing strong consumer recovery. The announcement quickly…
DMN Stock Plunges 99.9% Since Peak, Trading at $0.0017 on NASDAQ
DMN stock trades at $0.0017 with 2.2B shares volume. Damon Inc. faces severe losses and receives C rating from Meyka AI.
INL.DE Intel Earnings Preview April 23, 2026
Intel (INL.DE) reports Q1 2026 earnings April 23. Analysts expect $0.0137 EPS and $10.75B revenue. Stock at €56.70.
RAFL.BO Stock Plunges 18% on BSE: Raghuvansh Agrofarms Faces Sharp Intraday Decline
RAFL.BO stock crashes 18.18% intraday on BSE. Raghuvansh Agrofarms Limited trades at ₹45, down from ₹55 previous close. Market analysis inside.
ALMDT.PA Median Technologies Earnings Preview April 23
Median Technologies earnings preview for April 23, 2026. Revenue estimate $11.30M. Medical imaging AI software company faces profitability challenges.
XIOR.BR Earnings Preview: Student Housing REIT Reports April 23
Xior Student Housing (XIOR.BR) earnings preview for April 23, 2026. Key metrics, valuation, and what to watch.
4AB.DU AbbVie Earnings Preview April 23, 2026
AbbVie (4AB.DU) reports earnings April 23. Pharma giant faces mixed signals with strong cash flow but declining profitability metrics.